Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2011-04-13 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages 102.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a daily notice rather than a full report. The content is focused on share repurchase activity, which aligns with the category for reports on company buying back its own shares. The document length is 2605 characters, which is consistent with a notice rather than a full financial report. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2011-04-13 English
Form 484 Cancellation and Issue of Shares 6 pages 161.3KB
Regulatory Filings
2011-04-13 English
Daily share buy-back notice - Appendix 3E 2 pages 100.3KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It is a regulatory notice specifically about the company's repurchase of its own shares. The document length is relatively short (2612 characters) and it is not an announcement of a report publication but the actual notice of share buy-back activity. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2011-04-12 English
Appendix 3B 7 pages 52.9KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the issuance of ordinary shares and performance rights/options under a Performance Rights Plan, including number of securities, issue price, purpose, and quotation application. The document is a formal announcement of new securities issued and application for their quotation on the ASX. It does not contain financial statements, management discussion, or audit information. It is a regulatory announcement specifically about capital issuance and securities quotation. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2011-04-12 English
Daily share buy-back notice - Appendix 3E 2 pages 102.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, and compliance statements. The document is short (2605 characters) and focuses on reporting daily share repurchase activity. This matches the description of a 'Transaction in Own Shares' filing, which reports company buy-back activities. It is not an announcement of a report, nor a full financial report, but a specific regulatory notice about share repurchases.
2011-04-11 English
Daily share buy-back notice - Appendix 3E 2 pages 102.7KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice to the exchange about share repurchase activity. The document length is 2662 characters, which is relatively short but contains substantive data about share buy-backs, not just an announcement of a report. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. It is not an announcement of a report publication, nor a general regulatory filing, but a specific transaction report. Therefore, the correct classification is POS with high confidence.
2011-04-10 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.